drugset / Trial / NCT00354094
[S,S]-Reboxetine Long Term Safety Study In Post-Shingles Pain.
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the long term (up to 2 years) safety and tolerability of \[S,S\]-Reboxetine in patients with pain after shingles.
Timeline
- Start
- 2006-11
- Primary completion
- —
- Completion
- 2007-10
Outcome
Outcome not reported
Stopped (Business): “The study was stopped due to business/operational issues.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [S,S]-Reboxetine | Unknown | — | — |
Indications
No indication recorded.